Mrv1909 12152018042D 10 9 0 0 0 0 999 V2000 1.0461 1.4289 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 1.7605 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7605 2.6664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.4750 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1895 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9039 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.6184 1.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3329 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0474 1.8414 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 5.3329 0.6039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 2 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 8 10 2 0 0 0 0 M CHG 2 1 -1 9 -1 M END > DB16084 > drugbank > [O-]C(=O)CCCCC([O-])=O > InChI=1S/C6H10O4/c7-5(8)3-1-2-4-6(9)10/h1-4H2,(H,7,8)(H,9,10)/p-2 > WNLRTRBMVRJNCN-UHFFFAOYSA-L > C6H8O4 > 144.127 > 144.043355897 > 4 > 18 > -1.996686505784964 > 13.362037395378337 > 1 > 0 > -2 > 0 > hexanedioate > 0.49 > 0.4906543626666667 > -0.53 > 0 > -2 > 0 > -2 > 4.697830626774094 > 3.9174684741961925 > 80.25999999999999 > 54.4132 > 5 > 1 > 5.28e+01 g/l > 2-methoxy-4-[(1E)-3-[4-(nitrooxy)butoxy]-3-oxoprop-1-en-1-yl]phenyl (4R)-4-[(1R,3aS,3bR,4S,5aS,7R,9aS,9bS,11aR)-4,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1H-cyclopenta[a]phenanthren-1-yl]pentanoate > 0 > DB16084 > investigational > Iron (III) oxide adipate > Adipate; Adipate dianion; Adipate ion; Adipate(2-); Adipic acid ion (2-); Hexanedioate dianion; Hexanedioic acid, ion(2-) $$$$